Drug Trial Radar · NCT02633046
Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria
Last checked: Nov 20, 2026Latest source record: Aug 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
63
Actual
Start
Oct 10, 2016
Primary completion
Aug 27, 2020
Study completion Aug 27, 2020
Sponsor
- Lead sponsor
- Mallinckrodt ARD LLCIndustry
- Sponsor type
- Industry
- First posted
- Dec 17, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Focal segmental glomerulosclerosis (FSGS) is a condition that harms the kidney "filters" that remove waste from the blood. Proteins are supposed to stay in the blood. Damaged "filters" let protein get into the kidney. FSGS is a serious condition that can lead to kidney failure. The only treatment for kidney failure is dialysis or kidney transplant. Proteinuria means too much protein came through the kidneys into the urine. If the doctor cannot figure out what is causing the problem, it is primary (idiopathic) FSGS. This kind of FSGS is very hard to treat. This study will test Acthar in patients with this condition who have not responded to other treatments. It primarily investigates how well the therapy is tolerated by the patients and how well they respond to this treatment.
Conditions
- Idiopathic Focal Segmental Glomerulosclerosis
Interventions
Acthar GelDrug
Acthar Gel 80 U/mL solution for subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse EventsTime frame: within 56 weeks
Locations
47 sites in 7 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
AKDHC Medical Research Services, LLC
Tucson, Arizona
California Institute of Renal Research
Chula Vista, California
Stanford University
Stanford, California
VERITAS Research Corp
Miami Lakes, Florida
Genesis Clinical Research Corp
Tampa, Florida
GA Nephrology
Lawrenceville, Georgia
NANI Research
Hinsdale, Illinois
University of Louisville Research Foundation, Inc.
Louisville, Kentucky
Ochsner Clinic Foundation, Baton Rouge
Baton Rouge, Louisiana
NKDHC Medical Research Services, LLC
Las Vegas, Nevada
Icahn School of Medicine-Mt. Sinai
New York, New York
Columbia University Medical Center
New York, New York
Metrolina Nephrology Associates
Charlotte, North Carolina
Brookview Hills Research Associates, LLC
Winston-Salem, North Carolina
University of Cincinnati Physicians Company, LLC
Cincinnati, Ohio
Cincinnati VA Medical Center
Cincinnati, Ohio
Medical University of South Carolina
Charleston, South Carolina
Texas Tech University Health Science Center
Amarillo, Texas
Texas Kidney Institute (Neprhotex Research Group)
Dallas, Texas
University of Wisconsin Wisconsin Dialysis Institute
Madison, Wisconsin
Sanatorio Allende
Córdoba, Argentina
Centro de Salud Renal Junín SRL
Junín, Buenos Aires, Argentina
Centro de Investigaciones Médicas
Mar del Plata, Buenos Aires, Argentina
Renal Research Group
Gosford, New South Wales, Australia
Liverpool Hospital
Liverpool, New South Wales, Australia
Westmead Hospita
Westmead, New South Wales, Australia
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia
Launceston Hospital
Launceston, Tasmania, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
Sunshine Hopital - Western Health
St Albans, Victoria, Australia
Hospital Dr. Hernán Henríquez Aravena
Temuco, Araucania, Chile
Clinica Davila
Santiago, RM, Chile
Investigación Nefrológica SC
Cuernavaca, Morelos, Mexico
Hospital y Clínica OCA S.A de C.V
Monterrey, Nuevo León, Mexico
Hospital Nacional Alberto Sabogal
Lima, Peru
Hospital Nacional Arzobispo Loayza
Lima, Peru
Hospital Nacional Hospital Maria Auxiliadora
Lima Lima, Peru
Hospital Nacional Cayetano Heredia
San Martín de Porres, Lima region, Peru
Ankara NumuneTraining and Research Hospital
Ankara, Turkey (Türkiye)
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.